Target intelligence / Profile preview

DDHD domain-containing protein 2 (DDHD2)

Target
DDHD2
Molecular classification
Enzyme, Triacylglycerol lipase, Phospholipase (specifically, phospholipase A1)
01

Overview

DDHD domain-containing protein 2 (DDHD2) is a phospholipase enzyme and triacylglycerol hydrolase that regulates lipid homeostasis in the central nervous system by catalyzing the hydrolysis of diacylglycerol and triacylglycerol and also acting as a phospholipase, preferably hydrolyzing phosphatidic acids. It contains functionally significant SAM, WWE, and DDHD domains, and participates in intracellular membrane trafficking, including mediating pathways between the endoplasmic reticulum and the Golgi apparatus. Mutations in DDHD2 disrupt lipid metabolism and trafficking and are associated with autosomal recessive spastic paraplegia type 54, a progressive neurodegenerative disease, as well as generalized epilepsy. The enzyme is widely expressed at the cytoplasmic level, especially in neural tissues, and is essential for neuronal triacylglycerol breakdown and membrane function.

Other names
Triacylglycerol hydrolase DDHD2KIAA0725SAMWD1TAG hydrolaseSPG54p125BiPLA1gammaiPLA1γIntracellular phospholipase A1 gammaPhospholipase DDHD2Triglyceride hydrolase DDHD2Triglyceride lipasePA-PLA1 likeSec23p-interacting protein p125-like phosphatidic acid-preferring phospholipase A1EC 3.1.1.3KIAA0725pSAMWWE and DDHD domain-containing protein 1IPLA1AIPLA1G
02

Biological functions

Lipid homeostasis (lipid metabolism)Membrane traffickingGlycerophospholipid biosynthesis and catabolismCatabolism of diacylglycerol (DAG) and triacylglycerol (TAG)Maintenance of endoplasmic reticulum and Golgi structure and functionLipophagy (autophagic lipid degradation)
03

Disease associations

Neurodegenerative disease (notably, autosomal recessive spastic paraplegia type 54)Generalized epilepsy
04

Safety considerations

Loss-of-function mutations can cause severe neurodegenerative conditions, highlighting potential risk for CNS lipid homeostasis if inhibited or disrupted

Beyond the preview

Go deeper on DDHD domain-containing protein 2 (DDHD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDHD domain-containing protein 2 (DDHD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call